Oura Rings Up a $625 Million AI Doctor, Betting on Health Services Over Hardware

Oura, the company that built a market‑dominating smart ring, is buying AI‑native primary‑care startup Counsel Health for $625 million. The deal comes after Oura postponed its $2.2 billion IPO, citing uncertainty in the market, and follows Counsel’s integration into the Oura app in June. Counsel’s chat‑based medical platform lets users ask questions, receive AI‑generated advice, and connect with licensed physicians when needed—all inside the Oura app.

By adding a medical layer, Oura can now offer preventive, acute, specialty, and chronic care, turning the ring into a health hub. Counsel’s AI works by analyzing Oura’s biometric data—sleep, heart rate, activity trends—and providing personalized medical guidance. Physicians remain in the loop for clinical decisions, ensuring safety and accountability.

Oura’s data gives clinicians objective context, turning raw numbers into actionable insights. The result is a more informed care experience that can be delivered at scale to Oura’s membership. Oura’s financials paint a picture of rapid growth: revenue jumped 153% year‑over‑year to $533 million in the quarter ended September 30, and the fiscal 2026 total reached $1.75 billion, a 92% increase.

The company’s valuation hit $11 billion after a $900 million late‑stage round in October 2025.

Our read: the acquisition signals a strategic pivot from hardware to services, a move that could sustain Oura’s valuation growth when the IPO market remains uncertain.

Counsel’s 70‑person team will stay on, with CEO Muthu Alagappan joining Oura as chief clinical AI officer.

The deal is expected to close before the end of 2027, but market volatility could delay integration.

Oura plans to expand its AI‑native care model beyond its membership, targeting enterprise partners and a broader consumer base.

Watch how Oura’s valuation and revenue trajectory align with this shift.

Will the ring evolve into a comprehensive health platform, or will hardware still dominate its identity?

The next few years will reveal whether Oura’s gamble on AI‑driven care pays off.